Their technology is nowhere near ready. They have
Post# of 72430
![Avatar](/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
There is NO way that a technology like this would be approved to use with Brilacidin when there isn't even a completed Phase 2. The powder formulation would have to be engineered for Brilacidin, and you can bet that they will want safety testing before using a powder form of a drug in people who are ill with lung infection and inflammation. This would be a long process.
If Brilacidin were to be used in some kind of inhaled form, it sure won't be this one in the near future, by which I mean by the end of 2020.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)